Histone deacetylation mediates the rejuvenation of osteoblastogenesis by the combination of 25(OH)D3 and parathyroid hormone in MSCs from elders

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 156-159

  Zhou, Shuanhu ^a,b   Geng, Shuo ^a,c   Glowacki, Julie ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Epigenetic regulation; Human marrow stromal cells; Osteoblastogenesis; Parathyroid hormone; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; HISTONE DEACETYLASE; MESSENGER RNA; PARATHYROID HORMONE; SMALL INTERFERING RNA;

ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; DEACETYLATION; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE DEACETYLATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOBLASTOGENESIS; REJUVENATION; RNA INTERFERENCE; VITAMIN D METABOLISM;

EID: 84881173297     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.09.002     Document Type: Article

References (18)

1. 3 in vitro, Calcified Tissue International 65 (1999)173-180. (Pubitemid 29350658)
2. S. Zhou, M.S. LeBoff, J. Glowacki, Vitamin D metabolism and action in human bone marrow stromal cells, Endocrinology 151 (2010) 14-22.
3. S. Geng, S. Zhou, J. Glowacki, Effects of 25-hydroxyvitamin D3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1a-hydroxylase, Journal of Bone and Mineral Research 26 (2011) 1145-1153.
4. S. Geng, S. Zhou, J. Glowacki, Age-related decline in 1a-hydroxylase/CYP27B1 and osteoblasto-genesis in human mesenchymal stem cells; stimulation by PTH, Aging Cell 10(2011)962-971.
5. S.M. Mueller, J. Glowacki, Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges, Journal of Cellular Biochemistry 82 (2001) 583-590. (Pubitemid 32720674)
6. S. Zhou, J.S. Greenberger, M.W. Epperly, J.P. Goff, C. Adler, M.S. Leboff, J. Glowacki, Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts, Aging Cell 7 (2008) 335-343. (Pubitemid 351663902)
7. G. D'Ippolito, P.C. Schiller, C. Ricordi, B.A. Roos, G.A. Howard, Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow, Journal of Bone and Mineral Research 14 (1999) 1115-1122. (Pubitemid 29314054)
8. S. Zhou, J. Glowacki, S.W. Kim, J. Hahne, S. Geng, S.M. Mueller, L Shen, I. Bleiberg, M.S. Leboff, Clinical characteristics influence in vitro action of 1, 25-dihydroxyvitamin D(3) in human marrow stromal cells, Journal of Bone and Mineral Research 27 (2012) 1992-2000.
9. S. Zhou, E.M. Bueno, S.W. Kim, I. Amato, L. Shen, J. Hahne, I. Bleiberg, P. Morley, J. Glowacki, Effects of age on parathyroid hormone signaling in human marrow stromal cells, Aging Cell 10(2011) 780-788.
10. P.C. Scacheri, O. Rozenblatt-Rosen, N.J. Caplen, T.G. Wolfsberg, L. Umayam, J.C. Lee, CM. Hughes, K.S. Shanmugam, A. Bhattacharjee, M. Meyerson, F.S. Collins, Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells, Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 1892-1897. (Pubitemid 38228987)
11. S.C. Khojasteh, S. Prabhu, J.R. Kenny, J.S. Halladay, A.Y. Lu, Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity, European Journal of Drug Metabolism and Pharmacokinetics 36 (2011) 1-16.
12. R.E. Sacco, B.J. Nonnecke, M.V. Palmer, W.R. Waters, J.D. Lippolis, T.A. Reinhardt, Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3, PLoS ONE 7 (2012) e33074.
13. M.R. Walters, D.M. Rosen, A.W. Norman, R.A. Luben, 1, 25-Dihydroxyvitamin D receptors in an established bone cell line. Correlation with biochemical responses, Journal of Biological Chemistry 257 (1982) 7481-7484. (Pubitemid 12002772)
14. H.M. Willems, E.G. van den Heuvel, G. Carmeliet, A. Schaafsma, J. Klein-Nulend, A.D. Bakker, VDR dependent and independent effects of 1, 25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts, Steroids 77 (2012) 126-131.
15. D. Menegaz, M.T. Mizwicki, A. Barrientos-Duran, N. Chen, H.L. Henry, A.W. Norman, Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP), Molecular Endocrinology 25 (2011) 1289-1300.
16. R. Samadfam, Q. Xia, D. Miao, G.N. Hendy, D. Goltzman, Exogenous PTH and endogenous 1, 25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone, Journal of Bone and Mineral Research 23 (2008) 1257-1266. (Pubitemid 352040180)
17. D.E. Sellmeyer, D.M. Black, L Palermo, S. Greenspan, K. Ensrud, J. Bilezikian, C.J. Rosen, Heterogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis, Osteoporosis International 18 (2007) 973-979. (Pubitemid 46889557)
18. P. Schwarz, N.R. Jorgensen, L Mosekilde, P. Vestergaard, Effects of increasing age dosage, and duration of PTH treatment on BMD increase-a meta-analysis, Calcified Tissue International 90 (2012) 165-173.